Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes

BACKGROUND: Immunotherapeutic early-phase clinical trials (ieCTs) increasingly adopt large expansion cohorts exploring novel agents across different tumor types. High-grade glioma (HGG) patients are usually excluded from these trials. METHODS: Data of patients with recurrent HGGs treated within mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Simonelli, Matteo, Persico, Pasquale, Capucetti, Arianna, Carenza, Claudia, Franzese, Sara, Lorenzi, Elena, Dipasquale, Angelo, Losurdo, Agnese, Giordano, Laura, Pessina, Federico, Navarria, Pierina, Politi, Letterio S, Mavilio, Domenico, Locati, Massimo, Della Bella, Silvia, Santoro, Armando, Bonecchi, Raffaella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661084/
https://www.ncbi.nlm.nih.gov/pubmed/34901858
http://dx.doi.org/10.1093/noajnl/vdab160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661084/
https://www.ncbi.nlm.nih.gov/pubmed/34901858
http://dx.doi.org/10.1093/noajnl/vdab160

Ejemplares similares